These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10082835)

  • 1. Corticotropin-releasing hormone expression is the major target for glucocorticoid feedback-control at the hypothalamic level.
    Kretz O; Reichardt HM; Schütz G; Bock R
    Brain Res; 1999 Feb; 818(2):488-91. PubMed ID: 10082835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats.
    Marcilhac A; Anglade G; Hery F; Siaud P
    Neurosci Lett; 1999 Mar; 262(2):89-92. PubMed ID: 10203238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
    J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased hypothalamic and adrenal angiotensin II receptor expression and adrenomedullary catecholamines in transgenic mice with impaired glucocorticoid receptor function.
    Jain P; Armando I; Juorio AV; Barden N; Benicky J; Saavedra JM
    Neuroendocrinology; 2004; 80(3):171-80. PubMed ID: 15583474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
    Whitnall MH
    J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback control of glucocorticoid production is established during fetal development.
    Reichardt HM; Schütz G
    Mol Med; 1996 Nov; 2(6):735-44. PubMed ID: 8972488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids.
    Müller MB; Landgraf R; Preil J; Sillaber I; Kresse AE; Keck ME; Zimmermann S; Holsboer F; Wurst W
    Endocrinology; 2000 Nov; 141(11):4262-9. PubMed ID: 11089561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of hypothalamic glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in mice.
    Laryea G; Arnett M; Muglia LJ
    Stress; 2015; 18(4):400-7. PubMed ID: 26068518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to Chronic Mild Stress Differentially Alters Corticotropin-Releasing Hormone and Arginine Vasopressin mRNA Expression in the Stress-Responsive Neurocircuitry of Male and Female Rats Prenatally Exposed to Alcohol.
    Lan N; Hellemans KG; Ellis L; Weinberg J
    Alcohol Clin Exp Res; 2015 Dec; 39(12):2414-21. PubMed ID: 26578428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus.
    Jeanneteau FD; Lambert WM; Ismaili N; Bath KG; Lee FS; Garabedian MJ; Chao MV
    Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1305-10. PubMed ID: 22232675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major pro-vasopressin-expressing and pro-vasopressin-deficient subpopulations of corticotropin-releasing hormone neurons in normal rats. Differential distributions within the paraventricular nucleus.
    Whitnall MH; Gainer H
    Neuroendocrinology; 1988 Feb; 47(2):176-80. PubMed ID: 3257815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
    Merali Z; Hayley S; Kent P; McIntosh J; Bédard T; Anisman H
    Behav Brain Res; 2009 Mar; 198(1):105-12. PubMed ID: 19014976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress.
    Meaney MJ; Diorio J; Francis D; Widdowson J; LaPlante P; Caldji C; Sharma S; Seckl JR; Plotsky PM
    Dev Neurosci; 1996; 18(1-2):49-72. PubMed ID: 8840086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons.
    Erkut ZA; Pool C; Swaab DF
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2066-73. PubMed ID: 9626140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm.
    Herman JP; Adams D; Prewitt C
    Neuroendocrinology; 1995 Feb; 61(2):180-90. PubMed ID: 7753337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P; Anisman H; Merali Z
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences.
    Schmidt MV; Sterlemann V; Wagner K; Niederleitner B; Ganea K; Liebl C; Deussing JM; Berger S; Schütz G; Holsboer F; Müller MB
    Endocrinology; 2009 Jun; 150(6):2709-16. PubMed ID: 19213843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.